                         SEQUENCE LISTING

<110>  THE SCRIPPS RESEARCH INSTITUTE
 
<120>  SEQUENCING POLYCLONAL ANTIBODIES DIRECTLY FROM SINGLE PARTICLE 
       BRYOEM DATA

<130>  TSRI-018WO00

<140>  PCT/US22/17756
<141>  2022-02-24

<160>  34    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1

<400>  1

Arg Thr Gly Ser Thr Ala Tyr Asn Pro 
1               5                   


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104 LC

<400>  2

Gln Asp Ile Ser Asn Tyr Tyr Ser Ser Gln Gln His Asn Ser Tyr Pro 
1               5                   10                  15      


Pro Thr 
        


<210>  3
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104 HC

<400>  3

Gly Gly Ser Phe Ser Gly Tyr Ser Ile Ile Gly Arg Thr Gly Ser Thr 
1               5                   10                  15      


Ala Arg Gln Gln Ser Asn Phe Asp Phe 
            20                  25  


<210>  4
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 LC

<400>  4

Gln Gly Ile Asn Lys Glu Gly Ala Ser Gln Gln Asp Tyr Thr Thr Pro 
1               5                   10                  15      


Trp Thr 
        


<210>  5
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 HC

<400>  5

Gly Gly Ser Phe Ser Gly Tyr Ser Ile Ile Gly Arg Thr Gly Ser Thr 
1               5                   10                  15      


Ala Arg Ala Arg Gly Gly Tyr Glu Asp Asp Asp Gly Tyr His Tyr Thr 
            20                  25                  30          


Gly Tyr Gly Leu Asp 
        35          


<210>  6
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FIG. 8 SEQ

<400>  6

Arg Lys Met Phe Met Thr Thr Val Ile Leu His Asn Asp Gln Glu Ala 
1               5                   10                  15      


Ser Cys Thr Val Tyr Phe His Trp 
            20                  


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104 PAbC LC (Res 94-102)

<400>  7

Tyr Pro Arg Thr Phe Gly Gln Gly Thr 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104 PAbC.1 HC (Res 102-110)

<400>  8

Ser Asn Phe Asp Phe Trp Gly Gln Gly 
1               5                   


<210>  9
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 LC Kappa FR1

<400>  9

Asp Gln Ile Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Thr Thr Cys Arg Ala Ser 
            20                  25      


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 LC Kappa CDR1

<400>  10

Gln Asp Ile Ser Asn Asp 
1               5       


<210>  11
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 LC Kappa FR2

<400>  11

Ile Ala Trp Tyr Gln Gln Lys Arg Gly Lys Ala Pro Lys Pro Ile Leu 
1               5                   10                  15      


Val 
    


<210>  12
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 LC Kappa FR3

<400>  12

Asn Leu Glu Ser Gly Val Pro Ser Met Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala 
            20                  25                  30          


Ser Tyr Phe Cys 
        35      


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 LC Kappa CDR3

<400>  13

Gln Gln Tyr Asn Ser Tyr Pro Arg Thr 
1               5                   


<210>  14
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 HC fr1

<400>  14

Gln Val Gln Leu Gln Gln Glu Ser Gly Pro Gly Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser 
            20                  25  


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 HC CDR1

<400>  15

Gly Gly Ser Phe Ser Gly Tyr Ser 
1               5               


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 HC FR2

<400>  16

Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile Gly 
1               5                   10                  15      


Ser 
    


<210>  17
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 HC CDR2

<400>  17

Ile Ile Gly Arg Thr Gly Ser Thr 
1               5               


<210>  18
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 HC FR3

<400>  18

Ala Tyr Asn Pro Ser Leu Thr Ser Arg Val Thr Ile Ser Arg Ser Thr 
1               5                   10                  15      


Ser Asn Asn Gln Phe Ser Leu Lys Leu Thr Ser Leu Thr Ala Ala Asp 
            20                  25                  30          


Thr Ala Val Tyr Tyr Cys 
        35              


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33104_PAbC.1 HC CDR3

<400>  19

Ala Arg Gln Gln Ser Asn Phe Asp Phe 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC LC (Res 32-40)

<400>  20

Gln Leu Cys Trp Tyr Gln Leu Lys Pro 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC (Res 107-115)

<400>  21

Asp Gly Tyr His Tyr Thr Gly Tyr Gly 
1               5                   


<210>  22
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC LC kappa FR1

<400>  22

Asp Gln Ile Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Thr Thr Cys Arg Ala Ser 
            20                  25      


<210>  23
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC LC kappa CDR1

<400>  23

Gln Gly Ile Asn Met Gln 
1               5       


<210>  24
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC LC kappa FR2

<400>  24

Leu Cys Trp Thr Gln Leu Lys Pro Gly Arg Ala Pro Thr Leu Leu Ile 
1               5                   10                  15      


Tyr 
    


<210>  25
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC LC kappa FR3

<400>  25

Gly Leu Gln Thr Gly Val Ser Ser Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asn Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Val Ala 
            20                  25                  30          


Thr Tyr Val Cys 
        35      


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC LC kappa CDR3

<400>  26

Gln Gln Asp Tyr Thr Thr Pro Phe Thr 
1               5                   


<210>  27
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC FR1

<400>  27

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Met Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Thr Ser 
            20                  25  


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC CDR1

<400>  28

Gly Tyr Thr Phe Thr Ser Tyr Asn 
1               5               


<210>  29
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC FR2

<400>  29

Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met Gly 
1               5                   10                  15      


Trp 
    


<210>  30
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC CDR2

<400>  30

Ile Asn Pro Asn Asn Gly Thr Thr 
1               5               


<210>  31
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC FR3

<400>  31

Asp Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg Asp Thr 
1               5                   10                  15      


Ser Thr Thr Thr Ala Tyr Met Gln Leu Asn Ser Leu Arg Ser Glu Asp 
            20                  25                  30          


Thr Ala Val Tyr Tyr Cys 
        35              


<210>  32
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rh.33172 PAbC HC CDR3

<400>  32

Ala Arg Ala Arg Gly Gly Tyr Glu Asp Asp Asp Gly Tyr His Tyr Thr 
1               5                   10                  15      


Gly Tyr Gly Leu Asp 
            20      


<210>  33
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fig 20 sequence HC

<400>  33

Gly Val Ile Ala His Thr Gly Ala Gln Met Val Met Val Met Gly Phe 
1               5                   10                  15      


Phe Phe Leu Glu Thr Ala Ile Met 
            20                  


<210>  34
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fig 20 sequence LC

<400>  34

Gly Ala Ala Val Tyr Leu Asp Thr Val Arg Val Ala Ala Ala Trp Ala 
1               5                   10                  15      


Met Glu His Ala Gly Met Phe 
            20              


